Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Erector spinae plane block versus thoracoscopic intercostal nerve block for pain after VATS lung surgery

Official title: Prospective, Randomized Comparative Study of an Anesthesiological, Ultrasound-Guided "Erector Spinae Plane Block" (ESPB) Versus a Surgical, Thoracoscopically-Guided "Intercostal Nerve Block" (ICNB) in "Video-Assisted Thoracoscopic" (VATS) Procedures, Evaluating Postoperative Analgesic Consumption, Postoperative Pain Perception, and Duration of the Procedure

Run by Sana Klinikum Offenbach · NCT07535697 · Data updated 2026-11-12

This compares two nerve-block techniques to see which gives better pain control after elective VATS lung surgery in adults.

More Regional Anesthesia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment72 (estimated)
SponsorSana Klinikum Offenbach
Academic / other
Locations1 site (Offenbach, Hesse)
StatusRecruiting
StartedMay 4, 2026
Main results expectedApril 30, 2027
Study endsMay 3, 2027
Registry record updatedMay 1, 2026
Trial IDNCT07535697 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older scheduled for elective VATS pulmonary resection (lobectomy, segmentectomy, wedge) who can give informed consent and do not have contraindications to regional anesthesia are ideal candidates.

Probably not a fit

People with chronic opioid use or chronic pain syndromes, active coagulopathy or ongoing therapeutic anticoagulation, recent chest surgery or intraoperative conversion to open thoracotomy, pregnancy, or inability to consent are unlikely to benefit from the trial results or to be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, prospective, randomized non-inferiority trial randomizes adults having elective VATS lung resections to receive either an ultrasound-guided erector spinae plane block (ESPB) performed by an anesthesiologist before anesthesia induction or a thoracoscopically-guided intercostal nerve block (ICNB) performed by the surgeon intraoperatively. Both groups receive a standardized dose of 25 mL ropivacaine 0.375% and standardized perioperative anesthesia and analgesia protocols. Primary outcomes include postoperative analgesic consumption and pain scores in the first 24 hours after surgery, with secondary monitoring for complications and pulmonary outcomes. Participants are screened to exclude chronic pain, chronic opioid or substance use, coagulopathy, recent chest surgery, pregnancy, and other factors that could affect safety or assessment.

Why it matters

Potential benefit: If one technique provides better pain control it could lower opioid needs, improve breathing and coughing, and reduce pulmonary complications after VATS.

How similar studies have gone: Both ESPB and ICNB have demonstrated reductions in postoperative pain and opioid use in prior studies, but direct comparisons have been limited and results across studies have been inconsistent.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Provision of written informed consent
* Adults (≥ 18 years of age)
* Elective video-assisted thoracoscopic surgery (VATS) for pulmonary resection (e.g., lobectomy, segmentectomy, wedge resection)

Exclusion Criteria:

* Lack of informed consent
* Language barrier
* Pregnancy or breastfeeding
* Known allergy to local anesthetics used in the study
* Infection at the injection site(s)
* History of complex chest wall surgery
* Revision surgery with a prior operation within the last 6 months
* Intraoperative conversion to open thoracotomy
* Chronic pain syndrome
* Fibromyalgia
* Chronic opioid use
* Chronic alcohol abuse
* Chronic substance abuse (e.g., THC, amphetamines, cocaine)
* History of psychiatric disorders (e.g., depression, schizophrenia)
* Impaired consciousness, cognition, or ability to communicate
* Known coagulopathy (including platelet count \< 80,000/µL or prolonged PTT/aPTT \>1.5× the upper limit of normal)
* Ongoing therapeutic anticoagulation

Where it's running

  • Sana Klinikum Offenbach
    Offenbach, Hesse, Germany
    Recruiting

Study contacts

  • Principal investigator: Haitham Mutlak, Prof. Dr. — Department of Anesthesiology, Intensive Care Medicine and Pain Therapy at Sana Klinikum Offenbach
  • Study coordinator: Prof. Dr. H. Mutlak
  • Email: haitham.mutlak@sana.de
  • Phone: 0049-69-8405-3802

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.